ARTICLE | Clinical News
NeXstar regulatory update
May 30, 1995 7:00 AM UTC
NeXstar Pharmaceuticals Inc. (NXTR) AmBisome, the Boulder, Colo., company's liposomal formulation of amphotericin B, received marketing approval in Israel to treat life-threatening systemic fungal in...